Showing 1 - 8 results of 8 for search 'W. Todd Lowther', query time: 0.03s Refine Results
  1. 1
    Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure

    Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure by William T. Booth, Noah B. Walker, W. Todd Lowther, Allyn C. Howlett

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Expression and purification of integral membrane fatty acid desaturases.

    Expression and purification of integral membrane fatty acid desaturases. by Haiqin Chen, Zhennan Gu, Hao Zhang, Mingxuan Wang, Wei Chen, W Todd Lowther, Yong Q Chen

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease

    Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease by Emily E. Oliver, Erin K. Hughes, Meaghan K. Puckett, Rong Chen, W. Todd Lowther, Allyn C. Howlett

    Published 2020-11-01
    Get full text
    Article
  4. 4
    Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria.

    Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. by Travis J Riedel, Lynnette C Johnson, John Knight, Roy R Hantgan, Ross P Holmes, W Todd Lowther

    Published 2011-01-01
    Get full text
    Article
  5. 5
    Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton

    Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton by Kimberly J. Nelson, Terri Messier, Stephanie Milczarek, Alexis Saaman, Stacie Beuschel, Uma Gandhi, Nicholas Heintz, Terrence L. Smalley, W. Todd Lowther, Brian Cunniff

    Published 2021-01-01
    Get full text
    Article
  6. 6
    Peroxiredoxins in Cancer and Response to Radiation Therapies

    Peroxiredoxins in Cancer and Response to Radiation Therapies by Tom E. Forshaw, Reetta Holmila, Kimberly J. Nelson, Joshua E. Lewis, Melissa L. Kemp, Allen W. Tsang, Leslie B. Poole, W. Todd Lowther, Cristina M. Furdui

    Published 2019-01-01
    Get full text
    Article
  7. 7
    Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric State

    Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric State by Tom E. Forshaw, Julie A. Reisz, Kimberly J. Nelson, Rajesh Gumpena, J. Reed Lawson, Thomas J. Jönsson, Hanzhi Wu, Jill E. Clodfelter, Lynnette C. Johnson, Cristina M. Furdui, W. Todd Lowther

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.

    Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma. by Brian Cunniff, Kheng Newick, Kimberly J Nelson, Alexandra N Wozniak, Stacie Beuschel, Bruce Leavitt, Anant Bhave, Kelly Butnor, Andreas Koenig, Edward T Chouchani, Andrew M James, Alexina C Haynes, W Todd Lowther, Michael P Murphy, Arti Shukla, Nicholas H Heintz

    Published 2015-01-01
    Get full text
    Article

Search Tools: